Skip to main content
Clinical Trials/CTRI/2025/03/082816
CTRI/2025/03/082816Not yet recruitingNot Applicable

Efficacy of Fractional Carbon Dioxide Laser versus topical Tretinoin 0.05 percent gel in the treatment of striae distensae in Indian skin phototypes: A comparative, split-abdomen study.

Christian Medical College vellore District Tamil Nadu State India pincode1 site in 1 country53 target enrollmentStarted: March 29, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
53
Locations
1
Primary Endpoint
Comparison of pictures for changes in the appearance and also width by dermoscopy assessment at 0 and 16 week .

Study Overview

Brief Summary

Striae distensae (SD) or stretch marks are linear atrophic dermal scars covered with flat atrophic epidermis. This study aims at comparing the efficacy and safety of Fractional CO2 laser alone and in combination with topical Tretinoin 0.05% gel in the treatment of striae distensae in skin of colour Fitzpatrick skin phototypes III, IV, V and VI.

As, there are not many studies that compares fractional CO2 laser versus topical tretinoin 0.05% gel for striae distensae in Indian skin types, our study will be usefull in comparing the efficacy of both these modalities in the treatment of striae distensae.

 All patients with SD visting our Dermatology, Venereology and Leprosy/Cosmetic Dermatology OPD seeking treatment for the same will be enrolled in our study after informed consent. Patients will be examined and extent of striae will be assessed. In patients having multiple sites of involvement, the site of maximum cosmetic concern over the abdomen  will be selected for intervention. Abdomen will be divided into two halfs keeping the longitudinal midline as the center. The lesions on the side to be treated  with Fractional CO2 laser will be randomly selected by using a chit method. The other side will be treated with topical tretinoin 0.05 % gel. The Tretinoin gel will be continued on a daily basis at night. A total of three laser sessions will be done with an interval of 1 month duration. Post procedure white soft paraffin will be recommended for daily application in the morning over the sites of treatment.  Patients will be assessed immediately post treatment for any redness, burning, pain or discomfort. They will also be followed up in the subsequent visits for any untoward complications like post inflammatory hyperpigmentation, infection, persistent erythema, ulcers, scarring and keloid formation. Photographs will be taken at baseline, before each session and at the end of 1 month after the last session.

In our study, the Global aesthetic improvement scale will be used for comparing the photographs at baseline with the final photographs 1 month after the last laser session by a single investigator. The patient satisfaction scores will be done 1 month after the last laser procedure. The width of the striae will also be assessed using dermoscopy prior to initiation of treatment and at 1 month after the last session.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant and Outcome Assessor Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • aged above 18 years and above and willing for participate in the study.

Exclusion Criteria

  • Pregnant or lactating women.
  • Patients with severe cardiac, brain, liver or kidney failure, Malnutrition.
  • Patients who have been treated in the previous 6 months with lasers or chemical peels.
  • Patients with active infection.
  • History of keloid formation.
  • Patients with autoimmune diseases, Cushing’s syndrome and polycystic ovary syndrome.
  • History of systemic steroid treatment, systemic retinoid therapy.
  • Unable to visit for regular treatment sessions.

Outcomes

Primary Outcomes

Comparison of pictures for changes in the appearance and also width by dermoscopy assessment at 0 and 16 week .

Time Frame: Assessments will be done by comparing at 0 week and at the end of 16 week of the study

Secondary Outcomes

  • change in appearance of stretch marks(at baseline after 4 weeks at 8 weeks & final assessment is at 16 weeks)

Investigators

Sponsor
Christian Medical College vellore District Tamil Nadu State India pincode
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr VEENA V T

CHRISTIAN MEDICAL COLLEGE, VELLORE, TAMIL NADU

Study Sites (1)

Loading locations...

Similar Trials